Phase 3 Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children and teenagers between 5 and 18 years old
- Those who are obese, meaning their body weight measurement (BMI) is above the 97th percentile for their age and gender, based on World Health Organization growth charts
- A parent or guardian has given formal written consent for the child to take part
- The child is covered by the national health insurance system
Who may not be able to join:
- Children who are showing symptoms of vitamin D deficiency, such as muscle weakness, muscle spasms (tetany), or seizures related to low calcium levels
- Children who have taken vitamin D supplements in the 3 months before the first study visit
- Children whose bone X-rays show signs of rickets, such as weakened, thinning, or abnormally shaped bones
- Children with certain ongoing health conditions, including granulomatous diseases, Williams syndrome, hypothyroidism, liver or kidney disease, gut absorption problems, or abnormally high calcium levels in the blood
- Children with too much calcium in their urine, calcium kidney stones, abnormally high vitamin D levels, or calcium deposits in the kidneys
- Children currently taking anticonvulsant medications, barbiturates, or steroid medications
- Children currently taking a type of water tablet (diuretic) called a thiazide diuretic
- Children with a known allergy or sensitivity to the type of medication being studied
- Children who are pregnant or breastfeeding
- Children who are unable to follow the study procedures due to language barriers, psychological difficulties, or similar reasons
- Children already enrolled in another clinical study that could affect the results of this trial
- Children who are under legal protection or whose freedom is legally restricted (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Carine Villanueva, Hospices Civils de Lyon
Phone: 4 27 85 53 28
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients reaching the therapeutic target defined as vitamin D (25(OH)D) serum level ≥ 50 nmol/L and < 120 nmol/L
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.